Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$46.28 - $75.01 $92,560 - $150,020
-2,000 Reduced 40.0%
3,000 $207,000
Q1 2023

Apr 21, 2023

SELL
$43.42 - $57.37 $10.3 Million - $13.5 Million
-236,100 Reduced 97.93%
5,000 $241,000
Q1 2023

Apr 19, 2023

BUY
$43.42 - $57.37 $10.3 Million - $13.5 Million
236,100 Added 4722.0%
241,100 $11.6 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $55.0 $167,700 - $275,000
5,000 New
5,000 $275,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.